SlideShare a Scribd company logo
1 of 22
Objective Questions
1)
Hypersensitivity is due to
A)
The presence of an antigen.
B)
Immunity.
C)
The presence of antibodies.
D)
An altered immune response.
E)
Allergies.
2)
The chemical mediators of anaphylaxis are
A)
Found in basophils and mast cells.
B)
Antibodies.
C)
Antigens.
D)
Antigen-antibody complexes.
E)
The proteins of the complement system.
3)
Which of the following may result from systemic anaphylaxis?
A)
Hay fever
B)
Asthma
C)
Shock
D)
Hives
E)
None of the above
4)
Which antibodies will be in the serum of a person with blood type B, Rh-?
A)
Anti A, anti B, anti Rh
B)
Anti A, anti Rh
C)
Anti A
D)
Anti B, anti Rh
E)
Anti B
5)
Which type of transplant is least compatible?
A)
Autograft
B)
Allograft
C)
Isograft
D)
Xenotransplant
E)
None of the above
6)
Which of the following is not used to determine relatedness between a donor and a recipient for transplants?
A)
ABO antigens
B)
ABO antibodies
C)
MHC antigens
D)
MHC antibodies
E)
None of the above
7)
Graft-versus-host disease will most likely be a complication of
A)
A skin graft.
B)
A bone marrow transplant.
C)
A blood transfusion.
D)
An Rh incompatibility between mother and fetus.
E)
All of the above.
8)
Which of the following is not an immune complex disease?
A)
Rheumatic fever
B)
Systemic lupus erythematosus
C)
Hemolytic disease of the newborn
D)
Glomerulonephritis
E)
None of the above
9)
Cancer cells may escape the immune system because
A)
They are recognized as "self."
B)
Antibodies are not formed against cancer cells.
C)
Killer T cells react with tumor-specific antigens.
D)
Tumor cells shed their specific antigens.
E)
None of the above.
10)
The symptoms of an immune complex reaction are due to
A)
Destruction of the antigen.
B)
Complement fixation.
C)
Phagocytosis.
D)
Antibodies against self.
E)
None of the above.
11)
Autoimmunity is due to
A)
IgG and IgM antibodies.
B)
IgA antibodies.
C)
IgD antibodies.
D)
IgE antibodies.
E)
All of the above.
12)
Allergic contact dermatitis is due to
A)
Sensitized T cells.
B)
IgG antibodies.
C)
IgE antibodies.
D)
IgM antibodies.
E)
All of the above.
13)
Immunotoxins can be used to treat cancer because they
A)
Phagocytize foreign cells.
B)
Fix complement.
C)
Poison cells.
D)
Agglutinate cells.
E)
None of the above.
14)
Worldwide, the primary method of transmission of HIV is
A)
Heterosexual intercourse
B)
Homosexual intercourse
C)
Intravenous drug use
D)
Blood transfusions
E)
Nosocomial
15)
A hypersensitivity reaction occurs
A)
During the first exposure to an antigen.
B)
On a second or subsequent exposure to an antigen.
C)
In immunologically tolerant individuals.
D)
During autoimmune diseases.
E)
In individuals with diseases of the immune system.
16)
All of the following statements about type I hypersensitivities are true except
A)
They are cell mediated.
B)
They involve IgE antibodies.
C)
The symptoms are due to histamine.
D)
Antibodies are bound to host cells.
E)
The symptoms occur soon after exposure to an antigen.
17)
All of the following statements about type IV hypersensitivities are true except
A)
They are cell mediated.
B)
The symptoms occur within a few days after exposure to an antigen.
C)
They can be passively transferred with serum.
D)
The symptoms are due to lymphokines.
E)
They contribute to the symptoms of certain diseases.
18)
Which of the following blood transfusions are incompatible?
Donor Recipient
1. AB, Rh- AB, Rh+
2. A, Rh+ A, Rh-
3. A, Rh+ O, Rh+
4. B, Rh- B, Rh+
5. B, Rh+ A, Rh+
A)
2 and 5
B)
1, 2, and 3
C)
2, 3, and 5
D)
3 and 4
E)
All of the above
19)
Hemolytic disease of the newborn can result from
A)
An Rh+ mother with an Rh- fetus.
B)
An Rh- mother with an Rh+ fetus.
C)
An AB mother with a B fetus.
D)
An AB mother with an O fetus.
E)
None of the above.
20)
Reaction of antigen with IgE antibodies attached to mast cells causes
A)
Lysis of the cells.
B)
Release of chemical mediators.
C)
Complement fixation.
D)
Agglutination.
E)
None of the above.
21)
Which of the following involves a monoclonal anti-tumor antibody and a toxin?
A)
Immunologic enhancement
B)
Immunologic surveillance
C)
Immunotherapy
D)
Immunosuppression
22)
Which of the following may be inherited or result from HIV infection?
A)
Immunologic enhancement
B)
Immunologic surveillance
C)
Immunotherapy
D)
Immunosuppression
23)
Treatment with certain drugs to reduce transplant rejection can cause
A)
Immunologic enhancement.
B)
Immunologic surveillance.
C)
Immunotherapy.
D)
Immunosuppression.
24)
Cancer cells avoid the immune system by
A)
Immunologic enhancement.
B)
Immunologic surveillance.
C)
Immunotherapy.
D)
Immunosuppression.
25)
Which of the following is the body's response to tumor-specific antigen?
A)
Immunologic enhancement
B)
Immunologic surveillance
C)
Immunotherapy
D)
Immunosuppression
26)
Which of the following results in increased susceptibility to infection?
A)
Immunologic enhancement
B)
Immunologic surveillance
C)
Immunotherapy
D)
Immunosuppression
27)
Hay fever is an example of
A)
Type I hypersensitivity.
B)
Type II hypersensitivity.
C)
Type III hypersensitivity.
D)
Type IV hypersensitivity.
E)
All of the above
28)
Transfusion reactions are an example of
A)
Type I hypersensitivity.
B)
Type II hypersensitivity.
C)
Type III hypersensitivity.
D)
Type IV hypersensitivity.
E)
All of the above
29)
Transplant rejection is an example of
A)
Type I hypersensitivity.
B)
Type II hypersensitivity.
C)
Type III hypersensitivity.
D)
Type IV hypersensitivity.
E)
All of the above
30)
Which one of the following statements about HIV is not true?
A)
The T-cell response triggers viral multiplication.
B)
HIV can be transmitted by cell-to-cell contact.
C)
Bone marrow can be a reservoir for future infection.
D)
Viral infection of TH cells results in signs elsewhere in the patient.
E)
HIV infection directly causes death.
31)
Someone with AIDS probably
A)
Does not make any antibodies.
B)
Makes T-dependent antibodies.
C)
Makes T-independent antibodies.
D)
Makes TC- and TD-dependent antibodies.
E)
None of the above.
32)
Which of the following is the least likely vaccine against HIV?
A)
Attenuated virus
B)
Glycoprotein
C)
Protein core
D)
Subunit
E)
None of the above
33)
Antibodies against HIV are ineffective for all of the following reasons except
A)
Antibodies aren't made against HIV.
B)
Transmission by cell-to-cell fusion.
C)
Antigenic change.
D)
Latency.
E)
Virus particles staying in vesicles.
34)
The outcome of an HIV infection could be all of the following except
A)
Latency.
B)
Slow production of new viruses.
C)
TC-killing of infected cells.
D)
Viral-killing of infected cells.
E)
None of the above.
35)
Which of these causes of glomerulonephritis leads to all the others?
A)
Antibodies against Streptococcus
B)
Circulating immune complexes
C)
Complement fixation
D)
Formation of immune complexes
E)
Production of IgG
36)
Which of these causes damage to kidney cells in glomerulonephritis?
A)
Antibodies against Streptococcus
B)
Circulating immune complexes
C)
Complement fixation
D)
Formation of immune complexes
E)
Production of IgG
37)
HIV is transmitted by all of the following except
A)
Homosexual activity.
B)
Heterosexual activity.
C)
Hypodermic needles.
D)
Mosquitoes.
E)
Human milk.
38)
Drugs, such as AZT and ddC, currently used to treat AIDS act by
A)
Stimulatory TH cells.
B)
Stopping DNA synthesis.
C)
Promoting antibody formation.
D)
Neutralizing the virus.
E)
All of the above.
39)
The following events occur if human cells expressing HLA-I are mixed with anti-HLA-I, complement, and trypan blue.
What step indicates the cells are HLA-I?
A)
Trypan blue enters the cells.
B)
The MAC makes a pore in the plasma membrane.
C)
Complement is fixed.
D)
Antibody binds to the cells.
E)
None of the above, the T cells are missing.
40)
Which of the following is not considered a type I hypersensitivity?
A)
Asthma
B)
Dust allergies
C)
Penicillin allergic reactions
D)
Pollen allergies
E)
Transplant rejections
41)
Immune deficiencies are caused by all of the following. Which one does not cause an acquired immune deficiency?
A)
Chromosomal-linked B-cell deficiency
B)
Cyclosporine to inhibit IL-2 secretion
C)
HIV infection
D)
Rapamycin to inhibit IL-2 action
E)
None of the above
42)
Which of the following describes a cytotoxic autoimmune reaction?
A)
Antibodies react to cell-surface antigens.
B)
Antibodies are not made.
C)
Cells are killed.
D)
Immune complexes form.
E)
Mediate by T cells.
43)
Clinical AIDS is diagnosed when
A)
A patient has lymphadenopathy.
B)
HIV is found in a patient by Western blotting.
C)
The CD4 T-cell count is <200/mm3.
D)
The patient has persistent diarrhea.
E)
The patient has antibodies against HIV.
44)
In rheumatoid arthritis, IgM, IgG, and complement deposit in joints. This is an example of
A)
Cytotoxic autoimmunity.
B)
Immune complex autoimmunity.
C)
Cell-mediated autoimmunity.
D)
Immunosuppression.
E)
Acquired immunodeficiency.
45)
MMR vaccine contains hydrolyzed gelatin. A person receiving this vaccine could develop an anaphylactic reaction if the
person has
A)
An immunodeficiency.
B)
Antibodies against eggs.
C)
Antibodies against gelatin.
D)
Received the influenza vaccine.
E)
None of the above.
Chapter testdoc3668
Chapter testdoc3668

More Related Content

What's hot

Hypersensitivity reactions
Hypersensitivity reactionsHypersensitivity reactions
Hypersensitivity reactionsSoujanya Pharm.D
 
Type II Hypersensitivity-Antibody mediated cytotoxic Hypersensitivity
Type II Hypersensitivity-Antibody mediated cytotoxic HypersensitivityType II Hypersensitivity-Antibody mediated cytotoxic Hypersensitivity
Type II Hypersensitivity-Antibody mediated cytotoxic HypersensitivityAnup Bajracharya
 
HLA and antigen presentation
HLA and antigen presentationHLA and antigen presentation
HLA and antigen presentationPooja Dhaka
 
Tolerance and autoimmunity
Tolerance and autoimmunityTolerance and autoimmunity
Tolerance and autoimmunityOmair Riaz
 
Humoral Immunity
Humoral ImmunityHumoral Immunity
Humoral Immunityedwinchowyw
 
Lymphocytes : Structure & immunological Function
Lymphocytes : Structure & immunological Function Lymphocytes : Structure & immunological Function
Lymphocytes : Structure & immunological Function Dr Alok Tripathi
 
Studying the Adaptive Immune Response - Tools for T & B Cell Research: Host D...
Studying the Adaptive Immune Response - Tools for T & B Cell Research: Host D...Studying the Adaptive Immune Response - Tools for T & B Cell Research: Host D...
Studying the Adaptive Immune Response - Tools for T & B Cell Research: Host D...QIAGEN
 
02.17.09(a): Types I - IV Immunopathology
02.17.09(a): Types I - IV Immunopathology02.17.09(a): Types I - IV Immunopathology
02.17.09(a): Types I - IV ImmunopathologyOpen.Michigan
 
Sevilya et al cell death and immunity 2015
Sevilya et al cell death and immunity 2015Sevilya et al cell death and immunity 2015
Sevilya et al cell death and immunity 2015Ziv Sevilya
 
T Cell and its differentiation
T Cell and its differentiationT Cell and its differentiation
T Cell and its differentiationKrishna Moorthy
 
Immunological tolerance
Immunological toleranceImmunological tolerance
Immunological toleranceimprovemed
 
Immunology v t-ly
Immunology v t-lyImmunology v t-ly
Immunology v t-lyMUBOSScz
 
Cell mediated Immunity
Cell mediated ImmunityCell mediated Immunity
Cell mediated ImmunityHelao Silas
 
Access to memory cells
Access to memory cellsAccess to memory cells
Access to memory cellseman youssif
 
Molecular mimicry
Molecular mimicryMolecular mimicry
Molecular mimicryshru1604
 

What's hot (20)

Hypersensitivity reactions
Hypersensitivity reactionsHypersensitivity reactions
Hypersensitivity reactions
 
Type II Hypersensitivity-Antibody mediated cytotoxic Hypersensitivity
Type II Hypersensitivity-Antibody mediated cytotoxic HypersensitivityType II Hypersensitivity-Antibody mediated cytotoxic Hypersensitivity
Type II Hypersensitivity-Antibody mediated cytotoxic Hypersensitivity
 
HLA and antigen presentation
HLA and antigen presentationHLA and antigen presentation
HLA and antigen presentation
 
MHC I molecules
MHC I  moleculesMHC I  molecules
MHC I molecules
 
Tolerance and autoimmunity
Tolerance and autoimmunityTolerance and autoimmunity
Tolerance and autoimmunity
 
Humoral Immunity
Humoral ImmunityHumoral Immunity
Humoral Immunity
 
Lymphocytes : Structure & immunological Function
Lymphocytes : Structure & immunological Function Lymphocytes : Structure & immunological Function
Lymphocytes : Structure & immunological Function
 
Studying the Adaptive Immune Response - Tools for T & B Cell Research: Host D...
Studying the Adaptive Immune Response - Tools for T & B Cell Research: Host D...Studying the Adaptive Immune Response - Tools for T & B Cell Research: Host D...
Studying the Adaptive Immune Response - Tools for T & B Cell Research: Host D...
 
Transplant rejection
Transplant rejectionTransplant rejection
Transplant rejection
 
histo
histohisto
histo
 
02.17.09(a): Types I - IV Immunopathology
02.17.09(a): Types I - IV Immunopathology02.17.09(a): Types I - IV Immunopathology
02.17.09(a): Types I - IV Immunopathology
 
Sevilya et al cell death and immunity 2015
Sevilya et al cell death and immunity 2015Sevilya et al cell death and immunity 2015
Sevilya et al cell death and immunity 2015
 
T Cell and its differentiation
T Cell and its differentiationT Cell and its differentiation
T Cell and its differentiation
 
Immunological tolerance
Immunological toleranceImmunological tolerance
Immunological tolerance
 
Hypersensitivity
HypersensitivityHypersensitivity
Hypersensitivity
 
Mhc
MhcMhc
Mhc
 
Immunology v t-ly
Immunology v t-lyImmunology v t-ly
Immunology v t-ly
 
Cell mediated Immunity
Cell mediated ImmunityCell mediated Immunity
Cell mediated Immunity
 
Access to memory cells
Access to memory cellsAccess to memory cells
Access to memory cells
 
Molecular mimicry
Molecular mimicryMolecular mimicry
Molecular mimicry
 

Similar to Chapter testdoc3668

ETAS_MCQ_02 immunodermatology
ETAS_MCQ_02 immunodermatologyETAS_MCQ_02 immunodermatology
ETAS_MCQ_02 immunodermatologyDerma202
 
2017留学生试卷-2021-2022-2线上试题-A卷.pdf
2017留学生试卷-2021-2022-2线上试题-A卷.pdf2017留学生试卷-2021-2022-2线上试题-A卷.pdf
2017留学生试卷-2021-2022-2线上试题-A卷.pdfSamikshyaKharel
 
AS Level AQA unit 1: Topic 6 Immunity
AS Level AQA unit 1: Topic 6 ImmunityAS Level AQA unit 1: Topic 6 Immunity
AS Level AQA unit 1: Topic 6 Immunitysupe-saiyan
 
Hypersensitivity reactions.pptx
Hypersensitivity reactions.pptxHypersensitivity reactions.pptx
Hypersensitivity reactions.pptxRajesh Yadav
 
Immunology and immunodiagnostics mcq
Immunology and immunodiagnostics mcqImmunology and immunodiagnostics mcq
Immunology and immunodiagnostics mcqAfra Fathima
 
Innovation+11+booklet+2
Innovation+11+booklet+2Innovation+11+booklet+2
Innovation+11+booklet+2sallamahmed1
 
Document from lama
Document from lamaDocument from lama
Document from lamaLama K Banna
 
Tolerance &amp; autoimmunity and organ specific autoimmune diseases
Tolerance &amp; autoimmunity and organ specific autoimmune diseasesTolerance &amp; autoimmunity and organ specific autoimmune diseases
Tolerance &amp; autoimmunity and organ specific autoimmune diseasesdr.Ihsan alsaimary
 
Lecture 15 AIDS .pptx
Lecture 15 AIDS .pptxLecture 15 AIDS .pptx
Lecture 15 AIDS .pptxssuser3ef762
 
Blood Typing Lab Report
Blood Typing Lab ReportBlood Typing Lab Report
Blood Typing Lab ReportAimee Brown
 
Immunity and its cells, HLA and transplant rejection
Immunity and its cells, HLA and transplant rejectionImmunity and its cells, HLA and transplant rejection
Immunity and its cells, HLA and transplant rejectionJuliya Susan Reji
 
public health officer Loksewa 2077-10-19 first paper
public health officer Loksewa 2077-10-19 first paper public health officer Loksewa 2077-10-19 first paper
public health officer Loksewa 2077-10-19 first paper Public Health
 
Immunologic Disorders ppt
Immunologic Disorders pptImmunologic Disorders ppt
Immunologic Disorders pptSANJAY SIR
 

Similar to Chapter testdoc3668 (20)

ETAS_MCQ_02 immunodermatology
ETAS_MCQ_02 immunodermatologyETAS_MCQ_02 immunodermatology
ETAS_MCQ_02 immunodermatology
 
Immunology
ImmunologyImmunology
Immunology
 
MCQs.docx
MCQs.docxMCQs.docx
MCQs.docx
 
2017留学生试卷-2021-2022-2线上试题-A卷.pdf
2017留学生试卷-2021-2022-2线上试题-A卷.pdf2017留学生试卷-2021-2022-2线上试题-A卷.pdf
2017留学生试卷-2021-2022-2线上试题-A卷.pdf
 
AS Level AQA unit 1: Topic 6 Immunity
AS Level AQA unit 1: Topic 6 ImmunityAS Level AQA unit 1: Topic 6 Immunity
AS Level AQA unit 1: Topic 6 Immunity
 
Hypersensitivity reactions.pptx
Hypersensitivity reactions.pptxHypersensitivity reactions.pptx
Hypersensitivity reactions.pptx
 
Immunology and immunodiagnostics mcq
Immunology and immunodiagnostics mcqImmunology and immunodiagnostics mcq
Immunology and immunodiagnostics mcq
 
Innovation+11+booklet+2
Innovation+11+booklet+2Innovation+11+booklet+2
Innovation+11+booklet+2
 
hiv_resistance_clicker.ppt
hiv_resistance_clicker.ppthiv_resistance_clicker.ppt
hiv_resistance_clicker.ppt
 
IMMUNE RESPONSE
IMMUNE RESPONSEIMMUNE RESPONSE
IMMUNE RESPONSE
 
Immune disorders
Immune disorders Immune disorders
Immune disorders
 
Document from lama
Document from lamaDocument from lama
Document from lama
 
Tolerance &amp; autoimmunity and organ specific autoimmune diseases
Tolerance &amp; autoimmunity and organ specific autoimmune diseasesTolerance &amp; autoimmunity and organ specific autoimmune diseases
Tolerance &amp; autoimmunity and organ specific autoimmune diseases
 
Lecture 15 AIDS .pptx
Lecture 15 AIDS .pptxLecture 15 AIDS .pptx
Lecture 15 AIDS .pptx
 
Blood Typing Lab Report
Blood Typing Lab ReportBlood Typing Lab Report
Blood Typing Lab Report
 
Chapter 30
Chapter 30Chapter 30
Chapter 30
 
Immunity and its cells, HLA and transplant rejection
Immunity and its cells, HLA and transplant rejectionImmunity and its cells, HLA and transplant rejection
Immunity and its cells, HLA and transplant rejection
 
public health officer Loksewa 2077-10-19 first paper
public health officer Loksewa 2077-10-19 first paper public health officer Loksewa 2077-10-19 first paper
public health officer Loksewa 2077-10-19 first paper
 
Transplantation immunology
Transplantation immunologyTransplantation immunology
Transplantation immunology
 
Immunologic Disorders ppt
Immunologic Disorders pptImmunologic Disorders ppt
Immunologic Disorders ppt
 

More from Cleophas Rwemera

Chapter003 150907175411-lva1-app6891
Chapter003 150907175411-lva1-app6891Chapter003 150907175411-lva1-app6891
Chapter003 150907175411-lva1-app6891Cleophas Rwemera
 
Chapter002 150831173907-lva1-app6892
Chapter002 150831173907-lva1-app6892Chapter002 150831173907-lva1-app6892
Chapter002 150831173907-lva1-app6892Cleophas Rwemera
 
Chapter001 150823230128-lva1-app6892
Chapter001 150823230128-lva1-app6892Chapter001 150823230128-lva1-app6892
Chapter001 150823230128-lva1-app6892Cleophas Rwemera
 
Chapter25 cancer-140105085413-phpapp01
Chapter25 cancer-140105085413-phpapp01Chapter25 cancer-140105085413-phpapp01
Chapter25 cancer-140105085413-phpapp01Cleophas Rwemera
 
Chapter24 immunology-140105101108-phpapp02
Chapter24 immunology-140105101108-phpapp02Chapter24 immunology-140105101108-phpapp02
Chapter24 immunology-140105101108-phpapp02Cleophas Rwemera
 
Chapter23 nervecells-140105100942-phpapp02
Chapter23 nervecells-140105100942-phpapp02Chapter23 nervecells-140105100942-phpapp02
Chapter23 nervecells-140105100942-phpapp02Cleophas Rwemera
 
Chapter22 themolecularcellbiologyofdevelopment-140105100412-phpapp02
Chapter22 themolecularcellbiologyofdevelopment-140105100412-phpapp02Chapter22 themolecularcellbiologyofdevelopment-140105100412-phpapp02
Chapter22 themolecularcellbiologyofdevelopment-140105100412-phpapp02Cleophas Rwemera
 
Chapter21 cellbirthlineageanddeath-140105095914-phpapp02
Chapter21 cellbirthlineageanddeath-140105095914-phpapp02Chapter21 cellbirthlineageanddeath-140105095914-phpapp02
Chapter21 cellbirthlineageanddeath-140105095914-phpapp02Cleophas Rwemera
 
Chapter20 regulatingtheeukaryoticcellcycle-140105095738-phpapp01
Chapter20 regulatingtheeukaryoticcellcycle-140105095738-phpapp01Chapter20 regulatingtheeukaryoticcellcycle-140105095738-phpapp01
Chapter20 regulatingtheeukaryoticcellcycle-140105095738-phpapp01Cleophas Rwemera
 
Chapter19 integratingcellsintotissues-140105095535-phpapp02
Chapter19 integratingcellsintotissues-140105095535-phpapp02Chapter19 integratingcellsintotissues-140105095535-phpapp02
Chapter19 integratingcellsintotissues-140105095535-phpapp02Cleophas Rwemera
 
Chapter18 cellorganizationandmovementiimicrotubulesandintermediatefilaments-1...
Chapter18 cellorganizationandmovementiimicrotubulesandintermediatefilaments-1...Chapter18 cellorganizationandmovementiimicrotubulesandintermediatefilaments-1...
Chapter18 cellorganizationandmovementiimicrotubulesandintermediatefilaments-1...Cleophas Rwemera
 
Chapter17 cellorganizationandmovementimicrofilaments-140105094810-phpapp02
Chapter17 cellorganizationandmovementimicrofilaments-140105094810-phpapp02Chapter17 cellorganizationandmovementimicrofilaments-140105094810-phpapp02
Chapter17 cellorganizationandmovementimicrofilaments-140105094810-phpapp02Cleophas Rwemera
 
Chapter16 cellsignalingiisignalingpathwaysthatcontrolgeneactivity-14010509451...
Chapter16 cellsignalingiisignalingpathwaysthatcontrolgeneactivity-14010509451...Chapter16 cellsignalingiisignalingpathwaysthatcontrolgeneactivity-14010509451...
Chapter16 cellsignalingiisignalingpathwaysthatcontrolgeneactivity-14010509451...Cleophas Rwemera
 
Chapter15 cellsignalingisignaltransductionandshort-termcellularresponses-1401...
Chapter15 cellsignalingisignaltransductionandshort-termcellularresponses-1401...Chapter15 cellsignalingisignaltransductionandshort-termcellularresponses-1401...
Chapter15 cellsignalingisignaltransductionandshort-termcellularresponses-1401...Cleophas Rwemera
 
Chapter14 vesiculartrafficsecretionandendocytosis-140105094215-phpapp01
Chapter14 vesiculartrafficsecretionandendocytosis-140105094215-phpapp01Chapter14 vesiculartrafficsecretionandendocytosis-140105094215-phpapp01
Chapter14 vesiculartrafficsecretionandendocytosis-140105094215-phpapp01Cleophas Rwemera
 
Chapter13 movingproteinsintomembranesandorganelles-140105094005-phpapp01
Chapter13 movingproteinsintomembranesandorganelles-140105094005-phpapp01Chapter13 movingproteinsintomembranesandorganelles-140105094005-phpapp01
Chapter13 movingproteinsintomembranesandorganelles-140105094005-phpapp01Cleophas Rwemera
 
Chapter12 cellularenergetics-140105093734-phpapp01
Chapter12 cellularenergetics-140105093734-phpapp01Chapter12 cellularenergetics-140105093734-phpapp01
Chapter12 cellularenergetics-140105093734-phpapp01Cleophas Rwemera
 
Chapter11 transmembranetransportofionsandsmallmolecules-140105092904-phpapp02
Chapter11 transmembranetransportofionsandsmallmolecules-140105092904-phpapp02Chapter11 transmembranetransportofionsandsmallmolecules-140105092904-phpapp02
Chapter11 transmembranetransportofionsandsmallmolecules-140105092904-phpapp02Cleophas Rwemera
 
Chapter10 biomembranestructure-140105093829-phpapp02
Chapter10 biomembranestructure-140105093829-phpapp02Chapter10 biomembranestructure-140105093829-phpapp02
Chapter10 biomembranestructure-140105093829-phpapp02Cleophas Rwemera
 
Chapter9 visualizingfractionatingandculturingcells-140105092245-phpapp01
Chapter9 visualizingfractionatingandculturingcells-140105092245-phpapp01Chapter9 visualizingfractionatingandculturingcells-140105092245-phpapp01
Chapter9 visualizingfractionatingandculturingcells-140105092245-phpapp01Cleophas Rwemera
 

More from Cleophas Rwemera (20)

Chapter003 150907175411-lva1-app6891
Chapter003 150907175411-lva1-app6891Chapter003 150907175411-lva1-app6891
Chapter003 150907175411-lva1-app6891
 
Chapter002 150831173907-lva1-app6892
Chapter002 150831173907-lva1-app6892Chapter002 150831173907-lva1-app6892
Chapter002 150831173907-lva1-app6892
 
Chapter001 150823230128-lva1-app6892
Chapter001 150823230128-lva1-app6892Chapter001 150823230128-lva1-app6892
Chapter001 150823230128-lva1-app6892
 
Chapter25 cancer-140105085413-phpapp01
Chapter25 cancer-140105085413-phpapp01Chapter25 cancer-140105085413-phpapp01
Chapter25 cancer-140105085413-phpapp01
 
Chapter24 immunology-140105101108-phpapp02
Chapter24 immunology-140105101108-phpapp02Chapter24 immunology-140105101108-phpapp02
Chapter24 immunology-140105101108-phpapp02
 
Chapter23 nervecells-140105100942-phpapp02
Chapter23 nervecells-140105100942-phpapp02Chapter23 nervecells-140105100942-phpapp02
Chapter23 nervecells-140105100942-phpapp02
 
Chapter22 themolecularcellbiologyofdevelopment-140105100412-phpapp02
Chapter22 themolecularcellbiologyofdevelopment-140105100412-phpapp02Chapter22 themolecularcellbiologyofdevelopment-140105100412-phpapp02
Chapter22 themolecularcellbiologyofdevelopment-140105100412-phpapp02
 
Chapter21 cellbirthlineageanddeath-140105095914-phpapp02
Chapter21 cellbirthlineageanddeath-140105095914-phpapp02Chapter21 cellbirthlineageanddeath-140105095914-phpapp02
Chapter21 cellbirthlineageanddeath-140105095914-phpapp02
 
Chapter20 regulatingtheeukaryoticcellcycle-140105095738-phpapp01
Chapter20 regulatingtheeukaryoticcellcycle-140105095738-phpapp01Chapter20 regulatingtheeukaryoticcellcycle-140105095738-phpapp01
Chapter20 regulatingtheeukaryoticcellcycle-140105095738-phpapp01
 
Chapter19 integratingcellsintotissues-140105095535-phpapp02
Chapter19 integratingcellsintotissues-140105095535-phpapp02Chapter19 integratingcellsintotissues-140105095535-phpapp02
Chapter19 integratingcellsintotissues-140105095535-phpapp02
 
Chapter18 cellorganizationandmovementiimicrotubulesandintermediatefilaments-1...
Chapter18 cellorganizationandmovementiimicrotubulesandintermediatefilaments-1...Chapter18 cellorganizationandmovementiimicrotubulesandintermediatefilaments-1...
Chapter18 cellorganizationandmovementiimicrotubulesandintermediatefilaments-1...
 
Chapter17 cellorganizationandmovementimicrofilaments-140105094810-phpapp02
Chapter17 cellorganizationandmovementimicrofilaments-140105094810-phpapp02Chapter17 cellorganizationandmovementimicrofilaments-140105094810-phpapp02
Chapter17 cellorganizationandmovementimicrofilaments-140105094810-phpapp02
 
Chapter16 cellsignalingiisignalingpathwaysthatcontrolgeneactivity-14010509451...
Chapter16 cellsignalingiisignalingpathwaysthatcontrolgeneactivity-14010509451...Chapter16 cellsignalingiisignalingpathwaysthatcontrolgeneactivity-14010509451...
Chapter16 cellsignalingiisignalingpathwaysthatcontrolgeneactivity-14010509451...
 
Chapter15 cellsignalingisignaltransductionandshort-termcellularresponses-1401...
Chapter15 cellsignalingisignaltransductionandshort-termcellularresponses-1401...Chapter15 cellsignalingisignaltransductionandshort-termcellularresponses-1401...
Chapter15 cellsignalingisignaltransductionandshort-termcellularresponses-1401...
 
Chapter14 vesiculartrafficsecretionandendocytosis-140105094215-phpapp01
Chapter14 vesiculartrafficsecretionandendocytosis-140105094215-phpapp01Chapter14 vesiculartrafficsecretionandendocytosis-140105094215-phpapp01
Chapter14 vesiculartrafficsecretionandendocytosis-140105094215-phpapp01
 
Chapter13 movingproteinsintomembranesandorganelles-140105094005-phpapp01
Chapter13 movingproteinsintomembranesandorganelles-140105094005-phpapp01Chapter13 movingproteinsintomembranesandorganelles-140105094005-phpapp01
Chapter13 movingproteinsintomembranesandorganelles-140105094005-phpapp01
 
Chapter12 cellularenergetics-140105093734-phpapp01
Chapter12 cellularenergetics-140105093734-phpapp01Chapter12 cellularenergetics-140105093734-phpapp01
Chapter12 cellularenergetics-140105093734-phpapp01
 
Chapter11 transmembranetransportofionsandsmallmolecules-140105092904-phpapp02
Chapter11 transmembranetransportofionsandsmallmolecules-140105092904-phpapp02Chapter11 transmembranetransportofionsandsmallmolecules-140105092904-phpapp02
Chapter11 transmembranetransportofionsandsmallmolecules-140105092904-phpapp02
 
Chapter10 biomembranestructure-140105093829-phpapp02
Chapter10 biomembranestructure-140105093829-phpapp02Chapter10 biomembranestructure-140105093829-phpapp02
Chapter10 biomembranestructure-140105093829-phpapp02
 
Chapter9 visualizingfractionatingandculturingcells-140105092245-phpapp01
Chapter9 visualizingfractionatingandculturingcells-140105092245-phpapp01Chapter9 visualizingfractionatingandculturingcells-140105092245-phpapp01
Chapter9 visualizingfractionatingandculturingcells-140105092245-phpapp01
 

Recently uploaded

Measures of Dispersion and Variability: Range, QD, AD and SD
Measures of Dispersion and Variability: Range, QD, AD and SDMeasures of Dispersion and Variability: Range, QD, AD and SD
Measures of Dispersion and Variability: Range, QD, AD and SDThiyagu K
 
Gardella_Mateo_IntellectualProperty.pdf.
Gardella_Mateo_IntellectualProperty.pdf.Gardella_Mateo_IntellectualProperty.pdf.
Gardella_Mateo_IntellectualProperty.pdf.MateoGardella
 
Russian Escort Service in Delhi 11k Hotel Foreigner Russian Call Girls in Delhi
Russian Escort Service in Delhi 11k Hotel Foreigner Russian Call Girls in DelhiRussian Escort Service in Delhi 11k Hotel Foreigner Russian Call Girls in Delhi
Russian Escort Service in Delhi 11k Hotel Foreigner Russian Call Girls in Delhikauryashika82
 
Application orientated numerical on hev.ppt
Application orientated numerical on hev.pptApplication orientated numerical on hev.ppt
Application orientated numerical on hev.pptRamjanShidvankar
 
Web & Social Media Analytics Previous Year Question Paper.pdf
Web & Social Media Analytics Previous Year Question Paper.pdfWeb & Social Media Analytics Previous Year Question Paper.pdf
Web & Social Media Analytics Previous Year Question Paper.pdfJayanti Pande
 
PROCESS RECORDING FORMAT.docx
PROCESS      RECORDING        FORMAT.docxPROCESS      RECORDING        FORMAT.docx
PROCESS RECORDING FORMAT.docxPoojaSen20
 
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...EduSkills OECD
 
Z Score,T Score, Percential Rank and Box Plot Graph
Z Score,T Score, Percential Rank and Box Plot GraphZ Score,T Score, Percential Rank and Box Plot Graph
Z Score,T Score, Percential Rank and Box Plot GraphThiyagu K
 
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptxSOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptxiammrhaywood
 
Nutritional Needs Presentation - HLTH 104
Nutritional Needs Presentation - HLTH 104Nutritional Needs Presentation - HLTH 104
Nutritional Needs Presentation - HLTH 104misteraugie
 
This PowerPoint helps students to consider the concept of infinity.
This PowerPoint helps students to consider the concept of infinity.This PowerPoint helps students to consider the concept of infinity.
This PowerPoint helps students to consider the concept of infinity.christianmathematics
 
Holdier Curriculum Vitae (April 2024).pdf
Holdier Curriculum Vitae (April 2024).pdfHoldier Curriculum Vitae (April 2024).pdf
Holdier Curriculum Vitae (April 2024).pdfagholdier
 
SECOND SEMESTER TOPIC COVERAGE SY 2023-2024 Trends, Networks, and Critical Th...
SECOND SEMESTER TOPIC COVERAGE SY 2023-2024 Trends, Networks, and Critical Th...SECOND SEMESTER TOPIC COVERAGE SY 2023-2024 Trends, Networks, and Critical Th...
SECOND SEMESTER TOPIC COVERAGE SY 2023-2024 Trends, Networks, and Critical Th...KokoStevan
 
fourth grading exam for kindergarten in writing
fourth grading exam for kindergarten in writingfourth grading exam for kindergarten in writing
fourth grading exam for kindergarten in writingTeacherCyreneCayanan
 
Paris 2024 Olympic Geographies - an activity
Paris 2024 Olympic Geographies - an activityParis 2024 Olympic Geographies - an activity
Paris 2024 Olympic Geographies - an activityGeoBlogs
 
How to Give a Domain for a Field in Odoo 17
How to Give a Domain for a Field in Odoo 17How to Give a Domain for a Field in Odoo 17
How to Give a Domain for a Field in Odoo 17Celine George
 
Introduction to Nonprofit Accounting: The Basics
Introduction to Nonprofit Accounting: The BasicsIntroduction to Nonprofit Accounting: The Basics
Introduction to Nonprofit Accounting: The BasicsTechSoup
 
ICT Role in 21st Century Education & its Challenges.pptx
ICT Role in 21st Century Education & its Challenges.pptxICT Role in 21st Century Education & its Challenges.pptx
ICT Role in 21st Century Education & its Challenges.pptxAreebaZafar22
 
1029-Danh muc Sach Giao Khoa khoi 6.pdf
1029-Danh muc Sach Giao Khoa khoi  6.pdf1029-Danh muc Sach Giao Khoa khoi  6.pdf
1029-Danh muc Sach Giao Khoa khoi 6.pdfQucHHunhnh
 

Recently uploaded (20)

Measures of Dispersion and Variability: Range, QD, AD and SD
Measures of Dispersion and Variability: Range, QD, AD and SDMeasures of Dispersion and Variability: Range, QD, AD and SD
Measures of Dispersion and Variability: Range, QD, AD and SD
 
Gardella_Mateo_IntellectualProperty.pdf.
Gardella_Mateo_IntellectualProperty.pdf.Gardella_Mateo_IntellectualProperty.pdf.
Gardella_Mateo_IntellectualProperty.pdf.
 
Russian Escort Service in Delhi 11k Hotel Foreigner Russian Call Girls in Delhi
Russian Escort Service in Delhi 11k Hotel Foreigner Russian Call Girls in DelhiRussian Escort Service in Delhi 11k Hotel Foreigner Russian Call Girls in Delhi
Russian Escort Service in Delhi 11k Hotel Foreigner Russian Call Girls in Delhi
 
Application orientated numerical on hev.ppt
Application orientated numerical on hev.pptApplication orientated numerical on hev.ppt
Application orientated numerical on hev.ppt
 
Web & Social Media Analytics Previous Year Question Paper.pdf
Web & Social Media Analytics Previous Year Question Paper.pdfWeb & Social Media Analytics Previous Year Question Paper.pdf
Web & Social Media Analytics Previous Year Question Paper.pdf
 
PROCESS RECORDING FORMAT.docx
PROCESS      RECORDING        FORMAT.docxPROCESS      RECORDING        FORMAT.docx
PROCESS RECORDING FORMAT.docx
 
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...
 
Z Score,T Score, Percential Rank and Box Plot Graph
Z Score,T Score, Percential Rank and Box Plot GraphZ Score,T Score, Percential Rank and Box Plot Graph
Z Score,T Score, Percential Rank and Box Plot Graph
 
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptxSOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx
 
Nutritional Needs Presentation - HLTH 104
Nutritional Needs Presentation - HLTH 104Nutritional Needs Presentation - HLTH 104
Nutritional Needs Presentation - HLTH 104
 
This PowerPoint helps students to consider the concept of infinity.
This PowerPoint helps students to consider the concept of infinity.This PowerPoint helps students to consider the concept of infinity.
This PowerPoint helps students to consider the concept of infinity.
 
Holdier Curriculum Vitae (April 2024).pdf
Holdier Curriculum Vitae (April 2024).pdfHoldier Curriculum Vitae (April 2024).pdf
Holdier Curriculum Vitae (April 2024).pdf
 
SECOND SEMESTER TOPIC COVERAGE SY 2023-2024 Trends, Networks, and Critical Th...
SECOND SEMESTER TOPIC COVERAGE SY 2023-2024 Trends, Networks, and Critical Th...SECOND SEMESTER TOPIC COVERAGE SY 2023-2024 Trends, Networks, and Critical Th...
SECOND SEMESTER TOPIC COVERAGE SY 2023-2024 Trends, Networks, and Critical Th...
 
fourth grading exam for kindergarten in writing
fourth grading exam for kindergarten in writingfourth grading exam for kindergarten in writing
fourth grading exam for kindergarten in writing
 
Paris 2024 Olympic Geographies - an activity
Paris 2024 Olympic Geographies - an activityParis 2024 Olympic Geographies - an activity
Paris 2024 Olympic Geographies - an activity
 
Mattingly "AI & Prompt Design: Structured Data, Assistants, & RAG"
Mattingly "AI & Prompt Design: Structured Data, Assistants, & RAG"Mattingly "AI & Prompt Design: Structured Data, Assistants, & RAG"
Mattingly "AI & Prompt Design: Structured Data, Assistants, & RAG"
 
How to Give a Domain for a Field in Odoo 17
How to Give a Domain for a Field in Odoo 17How to Give a Domain for a Field in Odoo 17
How to Give a Domain for a Field in Odoo 17
 
Introduction to Nonprofit Accounting: The Basics
Introduction to Nonprofit Accounting: The BasicsIntroduction to Nonprofit Accounting: The Basics
Introduction to Nonprofit Accounting: The Basics
 
ICT Role in 21st Century Education & its Challenges.pptx
ICT Role in 21st Century Education & its Challenges.pptxICT Role in 21st Century Education & its Challenges.pptx
ICT Role in 21st Century Education & its Challenges.pptx
 
1029-Danh muc Sach Giao Khoa khoi 6.pdf
1029-Danh muc Sach Giao Khoa khoi  6.pdf1029-Danh muc Sach Giao Khoa khoi  6.pdf
1029-Danh muc Sach Giao Khoa khoi 6.pdf
 

Chapter testdoc3668

  • 1. Objective Questions 1) Hypersensitivity is due to A) The presence of an antigen. B) Immunity. C) The presence of antibodies. D) An altered immune response. E) Allergies. 2) The chemical mediators of anaphylaxis are A) Found in basophils and mast cells. B) Antibodies. C) Antigens. D) Antigen-antibody complexes. E) The proteins of the complement system. 3) Which of the following may result from systemic anaphylaxis? A) Hay fever B)
  • 2. Asthma C) Shock D) Hives E) None of the above 4) Which antibodies will be in the serum of a person with blood type B, Rh-? A) Anti A, anti B, anti Rh B) Anti A, anti Rh C) Anti A D) Anti B, anti Rh E) Anti B 5) Which type of transplant is least compatible? A) Autograft B) Allograft C) Isograft D) Xenotransplant E)
  • 3. None of the above
  • 4. 6) Which of the following is not used to determine relatedness between a donor and a recipient for transplants? A) ABO antigens B) ABO antibodies C) MHC antigens D) MHC antibodies E) None of the above 7) Graft-versus-host disease will most likely be a complication of A) A skin graft. B) A bone marrow transplant. C) A blood transfusion. D) An Rh incompatibility between mother and fetus. E) All of the above. 8) Which of the following is not an immune complex disease? A) Rheumatic fever B) Systemic lupus erythematosus C)
  • 5. Hemolytic disease of the newborn D) Glomerulonephritis E) None of the above 9) Cancer cells may escape the immune system because A) They are recognized as "self." B) Antibodies are not formed against cancer cells. C) Killer T cells react with tumor-specific antigens. D) Tumor cells shed their specific antigens. E) None of the above. 10) The symptoms of an immune complex reaction are due to A) Destruction of the antigen. B) Complement fixation. C) Phagocytosis. D) Antibodies against self. E) None of the above. 11)
  • 6. Autoimmunity is due to A) IgG and IgM antibodies. B) IgA antibodies. C) IgD antibodies. D) IgE antibodies. E) All of the above. 12) Allergic contact dermatitis is due to A) Sensitized T cells. B) IgG antibodies. C) IgE antibodies. D) IgM antibodies. E) All of the above. 13) Immunotoxins can be used to treat cancer because they A) Phagocytize foreign cells. B) Fix complement. C)
  • 7. Poison cells. D) Agglutinate cells. E) None of the above. 14) Worldwide, the primary method of transmission of HIV is A) Heterosexual intercourse B) Homosexual intercourse C) Intravenous drug use D) Blood transfusions E) Nosocomial 15) A hypersensitivity reaction occurs A) During the first exposure to an antigen. B) On a second or subsequent exposure to an antigen. C) In immunologically tolerant individuals. D) During autoimmune diseases. E) In individuals with diseases of the immune system.
  • 8. 16) All of the following statements about type I hypersensitivities are true except A) They are cell mediated. B) They involve IgE antibodies. C) The symptoms are due to histamine. D) Antibodies are bound to host cells. E) The symptoms occur soon after exposure to an antigen. 17) All of the following statements about type IV hypersensitivities are true except A) They are cell mediated. B) The symptoms occur within a few days after exposure to an antigen. C) They can be passively transferred with serum. D) The symptoms are due to lymphokines. E) They contribute to the symptoms of certain diseases. 18) Which of the following blood transfusions are incompatible? Donor Recipient 1. AB, Rh- AB, Rh+ 2. A, Rh+ A, Rh- 3. A, Rh+ O, Rh+ 4. B, Rh- B, Rh+ 5. B, Rh+ A, Rh+
  • 9. A) 2 and 5 B) 1, 2, and 3 C) 2, 3, and 5 D) 3 and 4 E) All of the above 19) Hemolytic disease of the newborn can result from A) An Rh+ mother with an Rh- fetus. B) An Rh- mother with an Rh+ fetus. C) An AB mother with a B fetus. D) An AB mother with an O fetus. E) None of the above.
  • 10. 20) Reaction of antigen with IgE antibodies attached to mast cells causes A) Lysis of the cells. B) Release of chemical mediators. C) Complement fixation. D) Agglutination. E) None of the above. 21) Which of the following involves a monoclonal anti-tumor antibody and a toxin? A) Immunologic enhancement B) Immunologic surveillance C) Immunotherapy D) Immunosuppression 22) Which of the following may be inherited or result from HIV infection? A) Immunologic enhancement B) Immunologic surveillance C) Immunotherapy
  • 11. D) Immunosuppression 23) Treatment with certain drugs to reduce transplant rejection can cause A) Immunologic enhancement. B) Immunologic surveillance. C) Immunotherapy. D) Immunosuppression. 24) Cancer cells avoid the immune system by A) Immunologic enhancement. B) Immunologic surveillance. C) Immunotherapy. D) Immunosuppression. 25) Which of the following is the body's response to tumor-specific antigen? A) Immunologic enhancement B) Immunologic surveillance C)
  • 13. 26) Which of the following results in increased susceptibility to infection? A) Immunologic enhancement B) Immunologic surveillance C) Immunotherapy D) Immunosuppression 27) Hay fever is an example of A) Type I hypersensitivity. B) Type II hypersensitivity. C) Type III hypersensitivity. D) Type IV hypersensitivity. E) All of the above 28) Transfusion reactions are an example of A) Type I hypersensitivity. B) Type II hypersensitivity. C) Type III hypersensitivity.
  • 14. D) Type IV hypersensitivity. E) All of the above 29) Transplant rejection is an example of A) Type I hypersensitivity. B) Type II hypersensitivity. C) Type III hypersensitivity. D) Type IV hypersensitivity. E) All of the above 30) Which one of the following statements about HIV is not true? A) The T-cell response triggers viral multiplication. B) HIV can be transmitted by cell-to-cell contact. C) Bone marrow can be a reservoir for future infection. D) Viral infection of TH cells results in signs elsewhere in the patient. E) HIV infection directly causes death.
  • 15. 31) Someone with AIDS probably A) Does not make any antibodies. B) Makes T-dependent antibodies. C) Makes T-independent antibodies. D) Makes TC- and TD-dependent antibodies. E) None of the above. 32) Which of the following is the least likely vaccine against HIV? A) Attenuated virus B) Glycoprotein C) Protein core D) Subunit E) None of the above 33) Antibodies against HIV are ineffective for all of the following reasons except A) Antibodies aren't made against HIV. B) Transmission by cell-to-cell fusion. C)
  • 16. Antigenic change. D) Latency. E) Virus particles staying in vesicles. 34) The outcome of an HIV infection could be all of the following except A) Latency. B) Slow production of new viruses. C) TC-killing of infected cells. D) Viral-killing of infected cells. E) None of the above. 35) Which of these causes of glomerulonephritis leads to all the others? A) Antibodies against Streptococcus B) Circulating immune complexes C) Complement fixation D) Formation of immune complexes E) Production of IgG 36)
  • 17. Which of these causes damage to kidney cells in glomerulonephritis? A) Antibodies against Streptococcus B) Circulating immune complexes C) Complement fixation D) Formation of immune complexes E) Production of IgG 37) HIV is transmitted by all of the following except A) Homosexual activity. B) Heterosexual activity. C) Hypodermic needles. D) Mosquitoes. E) Human milk. 38) Drugs, such as AZT and ddC, currently used to treat AIDS act by A) Stimulatory TH cells. B) Stopping DNA synthesis. C)
  • 18. Promoting antibody formation. D) Neutralizing the virus. E) All of the above. 39) The following events occur if human cells expressing HLA-I are mixed with anti-HLA-I, complement, and trypan blue. What step indicates the cells are HLA-I? A) Trypan blue enters the cells. B) The MAC makes a pore in the plasma membrane. C) Complement is fixed. D) Antibody binds to the cells. E) None of the above, the T cells are missing. 40) Which of the following is not considered a type I hypersensitivity? A) Asthma B) Dust allergies C) Penicillin allergic reactions D) Pollen allergies E) Transplant rejections 41)
  • 19. Immune deficiencies are caused by all of the following. Which one does not cause an acquired immune deficiency? A) Chromosomal-linked B-cell deficiency B) Cyclosporine to inhibit IL-2 secretion C) HIV infection D) Rapamycin to inhibit IL-2 action E) None of the above 42) Which of the following describes a cytotoxic autoimmune reaction? A) Antibodies react to cell-surface antigens. B) Antibodies are not made. C) Cells are killed. D) Immune complexes form. E) Mediate by T cells. 43) Clinical AIDS is diagnosed when A) A patient has lymphadenopathy. B) HIV is found in a patient by Western blotting. C)
  • 20. The CD4 T-cell count is <200/mm3. D) The patient has persistent diarrhea. E) The patient has antibodies against HIV. 44) In rheumatoid arthritis, IgM, IgG, and complement deposit in joints. This is an example of A) Cytotoxic autoimmunity. B) Immune complex autoimmunity. C) Cell-mediated autoimmunity. D) Immunosuppression. E) Acquired immunodeficiency. 45) MMR vaccine contains hydrolyzed gelatin. A person receiving this vaccine could develop an anaphylactic reaction if the person has A) An immunodeficiency. B) Antibodies against eggs. C) Antibodies against gelatin. D) Received the influenza vaccine. E) None of the above.